Background The World Health Organization (WHO)
S
oil-transmitted helminths (STH) are a group of parasitic nematode worms causing human infection through contact with parasite eggs or larvae that thrive in the warm and moist soil of the world's tropical and subtropical countries. Of particular worldwide importance are Ascaris lumbricoides, Trichuris trichiura, Necator americanus, and Ancylostoma duodenale. 1 In 1999, the WHO estimated that these inburden from all tropical diseases, excluding malaria. An estimated 4.5 billion individuals might be infected with A. lumbricoides with T. trichiura hookworm. 5 School-aged children in developing countries bear the greatest health burden due to helminth infections. Factors influencing the prevalence of STH are hygiene, sanitation, socioeconomic level, educational level, and ecosystem differences. In Indonesia, the prevalence of STH remains high at of the environment. Four, single-dose antihelminthic drugs, albendazole, levamisole, mebendazole, and pyrantel pamoate, are available for the treatment of STH infections in pharmacological-based control programs. 8, 9 These drugs are recommended by the WHO. 9 The objective of this study was to compare the efficacy of mebendazole and levamisole, alone or in combination, for the treatment of STH.
Methods
We conducted an open randomized controlled trial in Secanggang, North Sumatera from August until children infected with STH. The inclusion criteria for subjects were primary school aged children, infected with STH, and had not taken antihelminthics for at least the one month prior to the study. Patients were excluded if they refused to swallow the antihelminthic or submit stool specimens after treatment, or had diarrhea, cough, or fever.
Prior to treatment, each participant underwent anthropometric assessment and completed a questionnaire on socioeconomic and hygiene status. Participants were randomly assigned following a simple randomization procedure (random table) into three groups. Group I received single-dose mebendazole mebendazole-levamisole combined.
Subjects' stool specimens were collected and examined at baseline, and on the 1 st nd rd , and 4 th weeks after treatment. Outcome measures were cure rate and egg reduction rate. Subjects were considered to be cured when no worm eggs were found in their stool specimens. All adverse reactions were recorded. Written consent was obtained from subjects' parents. This study was approved by the Medical Ethics Committee of the University of North Sumatra Medical School.
Statistical analyses were carried out by Kruskal-Wallis and Analysis of Variance (ANOVA) tests. Differences were considered to be statistically significant at P
Results
We performed stool examinations on 415 primary infections. We enrolled and randomly assigned them mebendazole-levamisole (Figure 1 ). infection. The baseline characteristics of each group were similar. Number of males and females in all groups was almost the same. The average age of subjects was height for all groups within normal limits. There were no statistically significant differences in the average number of eggs between the groups before treatment (Table 1) .
Drug effectiveness based on egg reduction rate (Table 2) was significantly different between group III (combination treatment) from group II (levamisole alone) each of the 1 st to 4 th week after treatment. There was no significant difference in egg reduction rate between group III and group I (mebendazole alone) each of the 1 st to 4 th weeks after treatment. We found significant differences in cure rates between group III (combination treatment) and group II (levamisole alone) each of the 1 st to 4 th weeks after treatment. No significant differences were found between group I (mebendazole alone) and group III ( Table 3) .
Discussion
We found the prevalence of STH in our study to Human intestinal helminths and malaria are among the most common infections in the developing world. One-third of the world's population is infected with one or more species of intestinal helminths, 11 and children are reported to have a prevalence rate Infection with T. trichiura and A. lumbricoides typically reaches the highest We hoped that our study results would help guide the WHO program, so schoolaged children were selected as the study sample since they are at high risk of STH infection. The mean age of subjects and females. The World Health Assembly urged the international community to take firm action against Parasite Control (PPC) set out to regularly deworm The WHO recommends mass treatment of children in school, where the prevalence of infection with schistosomes or intestinal 14 Antihelminthics used in this study were single-dose mebendazole and levamisole, alone or in combination. Both the selection of drugs and doses were based on WHO recommendations. Effective, broad-spectrum, single-dose, safe, and relatively inexpensive drugs are now available for the treatment of helminth infections. 15 The four drugs recommended All four anthelminthics are given as a single dose and are not recomThe goal of treatment for STH infections is to remove adult worms from the gastrointestinal tract. The drugs most commonly used for the eradication of STH infections are mebendazole and albendazole. Both agents are effective against ascaris in a single dose. However, in hookworm infections, a single dose of mebendazole has a low cure rate, and albendazole is more effective. Conversely, a single dose of albendazole is not effective in many cases of trichuriasis. Both pyrantel pamoate and levamisole are regarded as alternative drugs for the treatment of hookworm and ascaris infections, although the former is not effective for the treatment of trichuriasis and their doses are based on body weight. 1 Two indicators used to determine the efficacy of an antihelminthic in human medicine are the cure rate (CR) and the egg reduction rate (ERR). 18 A study in Zanzibar showed very high efficacy of mebendazole and levamisole alone or in combination against A. lumbricoides -dazole, and mebendazole-levamisole combination, respectively). Mebendazole alone and in combination with levamisole had better efficacy than levamisole alone for T. trichiura -ment, the egg reduction rate for hookworm infection mebendazole). 8 efficacy of levamisole against A. lumbricoides and A. lumbricoides infection. For hookworm infection, been reported. Levamisole had a varied effect against T. trichiura 19 In an Iranian study, treatment of STH with a single-dose
In our study at the end of the 4 th week of stool alone, and the combination, respectively. Cure rates alone, levamisole alone, and the combination, respectively. Mebendazole alone and in combination with levamisole were more effective than levamisole alone for ascariasis and trichuriasis STH infections. The efficacy of mebendazole did not differ significantly from that of its combination with levamisole.
Overall, side effects of antihelminthic drugs were negligible and important adverse events were virtually nonexistent. However, the safety of anthelminthic drugs is of utmost importance because large portions of the population are normally treated. 15 No adverse events were noted in our study.
A limitation of this study was that no blinding was done, so we cannot exclude the possibility of bias. Also, we did not assess the effectiveness of anthelminthics based on worm type. We only assessed the effect of worm infection on the occurrence of malnutrition. The malnutrition status was assessed by the percentage of body weight according to height. We found good nutritional status for all three groups of subjects studied. Further research will be needed to assess the effectiveness of anthelminthics by worm type and the effect of worm infections on children.
In conclusion, a single dose of mebendazole and its combination with levamisole have a better efficacy than a single dose of levamisole alone for STH treatment. The highest efficacy of these treatments is noted at the 4 th week after drug administration.
